Clinical InvestigationHereditary Renal Hypouricemia Type 1 and Autosomal Dominant Polycystic Kidney Disease
Section snippets
Subjects
All patients received information about the study, agreed to participate and signed an informed consent. All tests were performed in accordance with the standards of the institutional ethics committee that approved the project. A 40-year-old man (proband IV.1) was examined in the outpatient department, complaining of renal cysts: serum UA was 0.7 mg/dL, no medication; from 2012 medication TRITACE (ramipril), serum UA 0.9 mg/dL. Afterwards, the proband was referred to this department because of
Subjects
The serum UA concentration in the proband was 1.1 mg/dL and was expressed as an increase in the fractional excretion of UA (43%). The mother of the proband (70 years of age) has normal renal function with a serum of UA 3.5 mg/dL and a serum creatinine of 1.1 mg/dL. The mother's sister (66 years of age) has a UA serum level of 8.8 mg/dL, and the serum creatinine level was 1.9 mg/dL. The proband, his mother and sister did not have clinical symptoms of urolithiasis, nephrolithiasis, AKI or renal
DISCUSSION
Many genome-wide association studies have uncovered over 30 common sequence variants influencing serum UA concentrations in several genes, mostly in urate transporters SLC2A9, SLC22A12 and ABCG2.20., 21. Recent data suggest a new concept of renal UA transport—multimolecular complex “transportsome” that probably involves cooperation between multiple transporters.22 Further detailed studies concerning urate transporters and their interactions in rare hereditary disorder as is RHUC could clarify
CONCLUSIONS
In conclusion, the authors report the 1st family with extremely rare coexistence of renal hereditary disorders: RHUC type 1 and autosomal PKD.
Even with much research into renal UA transport, a complete understanding of the influence of serum UA concentrations and the molecular basis of the pathogenesis of RHUC has not yet been fully elucidated. Further investigation of the functional properties of SLC22A12 is needed to assess their potential research and clinical implications.
REFERENCES (22)
- et al.
Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia
Am J Hum Genet
(2008) - et al.
A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese
Kidney Int
(2004) - et al.
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans
J Biol Chem
(2008) - et al.
Novel homozygous insertion in SLC2A9 gene caused renal hypouricemia
Mol Genet Metab
(2011) - et al.
Molecular identification of a renal urate-anion exchanger that regulates blood urate levels
Nature
(2002) - et al.
Hereditary renal hypouricemia: a new Role for allopurinol?
J Am Med
(2014) - et al.
Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion
J Am Soc Nephrol
(2004) - et al.
Age and origin of the G774A mutation in SLC22A12 causing renal hypouricemia in Japanese
Clin Genet
(2008) - et al.
A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout
Arthritis Rheum
(2005) - et al.
Homozygous SLC2A9 mutations cause severe renal hypouricemia
J Am Soc Nephrol
(2010)
Recurrent EIARF and PRES with severe renal hypouricemia by compound heterozygous SLC2A9 mutation
Pediatrics
Cited by (17)
URAT1 and GLUT9 mutations in Spanish patients with renal hypouricemia
2018, Clinica Chimica ActaCitation Excerpt :Coincidentally, one of the adult patients with CKD, patient 1, also had ADPKD. Stiburkova and col. [42] recently described a similar case. Our genetic analysis results showed SLC22A12 mutations p.T467M and/or p.L415_G417del in all the Roma patients; missense mutation p.T467M was detected in seven patients of five families (four homozygous, two heterozygous and one compound heterozygous), while mutation p.L415_G417del was found in two patients (one heterozygous and one compound heterozygous) (Table 1).
Hereditary renal hypouricaemia type 1 and 2 in three Spanish children. Review of published paediatric cases
2019, NefrologiaCitation Excerpt :Hereditary renal hypouricaemia (HRH) is a rare and underdiagnosed genetic disorder, and is included in the group of rare diseases (ORPHA 94088). It is caused by an isolated defect in the renal transport of uric acid at the renal tubular level, either due to decreased reabsorption and/or increased secretion.1,2 In children over 1 year old and in adults, it must be suspected in the presence of persistent serum uric acid (UA) level of less than 2 mg/dl (119 μmol/l), with fractional excretion of UA (FEUA) above 10% (normal 7.25 ± 2.98%).3–5
The authors have no other conflicts of interest to disclose.
Supported by grants from the Czech Republic Ministry of Education, Youth and Sports (LH13245) and by institutional support from a program at Charles University in Prague (PRVOUK—P25/LF1/2, P24/LF1/3).